Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep-Oct;25(5):709-713.
doi: 10.1016/j.rpor.2020.06.005. Epub 2020 Jul 10.

Factors influencing the use of adaptive radiation therapy in vulvar carcinoma

Fawzi Abuhijla  1 , Samer Salah  2 , Maysa Al-Hussaini  3 , Issa Mohamed  1 , Imad Jaradat  1 , Abdulmajeed Dayyat  1 , Hanan Almasri  1 , Alaa Allozi  1 , Ayah Arjan  1 , Abdelatif Almousa  1 , Ramiz Abu-Hijlih  1
Affiliations

Factors influencing the use of adaptive radiation therapy in vulvar carcinoma

Fawzi Abuhijla et al. Rep Pract Oncol Radiother. 2020 Sep-Oct.

Abstract

Aim: We aim to evaluate the variables affecting the frequency of adaptive radiotherapy (ART) in vulvar cancer.

Background: ART may be needed throughout a definitive RT course for vulvar carcinoma due to changes in patient's anatomy and tumor response.

Materials and methods: Charts of patients charts who had been treated with definitive concurrent chemo-radiotherapy for vulvar carcinoma, between January 2015 and December 2019 were inquired. Radiation therapy was delivered using intensity modulated radiotherapy (IMRT) with daily image-guided radiotherapy (IGRT). ART was defined as re-simulation and re-planning based on deformation in the irradiated volume by more than 1 cm. Univariate analysis was conducted to study the impact of patient's demographics as well as tumor characteristics on the frequency of ART.

Results: 22 patients were eligible for analysis. Median age at diagnosis was 55 years (range 43-82). Radiotherapy dose was 60-66 Gy over 30-35 fractions (fx). Median primary tumor volume was 30cc (9-140). Median Body Mass Index (BMI) was 32 (range 21-40). Thirteen out of 22 patients (59%) required ART, with median timing at 25 fx (19-31). On univariate analysis, larger primary tumor volume (> = 30cc) was associated significantly with increased frequency of ART (p value = 0.0005). There was no significant impact of ART on the frequency with respect to patient's age, BMI, tumor stage, grade and location.

Conclusion: Changes in radiation target volume are common among vulvar carcinoma patients who are treated with definitive radiotherapy, especially large primary tumors. This review highlights the importance of ART for patients with vulvar carcinoma treated with definitive radiotherapy.

Keywords: Adaptive; Factors; Radiotherapy; Vulva.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Matching CT simulation scan (in purple) to the daily CBCT (in green) in axial, sagittal and coronal views, with significant difference at fraction 25 (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article).
Fig. 2
Fig. 2
Change in tumor volume in cc (on the left) between initial CT simulation and re-simulation during treatment.
See this image and copyright information in PMC

References

    1. Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. - PubMed
    1. Kang Y.J., Smith M., Barlow E., Coffey K., Hacker N., Canfell K. Vulvar cancer in high-income countries: increasing burden of disease. Int J Cancer. 2017;141(11):2174–2186. - PubMed
    1. Gill B.S., Bernard M.E., Lin J.F. Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: a National Cancer data Base (NCDB) analysis. Gynecol Oncol. 2015;137(3):365–372. - PubMed
    1. Mitra S., Sharma M.K., Kaur I. Vulvar carcinoma: dilemma, debates, and decisions. Cancer Manag Res. 2018;10:61–68. - PMC - PubMed
    1. Moore D.H., Ali S., Koh W.J. A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study. Gynecol Oncol. 2012;124(3):529–533. - PubMed